Pharmaceutical Reviews Update — Issue 9

See Pharmaceutical Reviews Update – Issue 9 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:

• the announcement of CADTH’s new Patient and Community Advisory Committee
• opportunities for stakeholder comments and feedback on proposed updates to CADTH’s pharmaceutical review programs, specifically:
  • Proposal to Enhance the Transparency of CADTH’s Review Reports and Recommendations
  • Proposal to Revise Category 1 Requirements for CADTH Single Technology Reviews
  • CADTH’s Proposed Reassessment Framework
• updates to the Procedure and Submission Guidelines for the CADTH Common Drug Review:
  • Revised process for pre-NOC submissions that may receive an NOD or NOC
  • the integration of the CADTH-INESSS process for joint engagement with clinical specialists
  • updated pharmacoeconomic requirements.